Skip to main content
logo
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
5.69
-0.17 (-2.82%)
Apr 9, 2026, 10:48 AM EDT - Market open

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
269287325688548715
Market Cap Growth
62.93%-11.61%-52.78%25.56%-23.35%17.04%
Enterprise Value
191.36202.14177.57619.45461.96615.56
Last Close Price
5.696.086.8817.3715.2523.89
PE Ratio
--3.22-6.95-11.82-9.78-13.27
PS Ratio
494.31513.747.5121.7525.3142.60
PB Ratio
4.44-4.61-2.42-31.2920.5262.03
P/TBV Ratio
-4.31-4.61-2.37-29.2918.3961.45
P/FCF Ratio
--4.61-4.79-13.90-9.5896.24
P/OCF Ratio
--4.61-4.80-13.91-9.6177.70
EV/Sales Ratio
342.33361.614.1019.5821.3336.67
EV/EBITDA Ratio
--2.23-2.83-9.72-7.64-10.03
EV/EBIT Ratio
--2.22-2.80-9.62-7.57-9.94
EV/FCF Ratio
--3.24-2.62-12.51-8.0782.86
Debt / Equity Ratio
0.000.000-0.0100
Debt / EBITDA Ratio
0.000.000.000.00-0.010.00
Debt / FCF Ratio
0.000.000.00-0.01-0.010.03
Net Debt / Equity Ratio
1.361.361.103.11-3.20-8.61
Net Debt / EBITDA Ratio
0.940.942.351.071.421.62
Net Debt / FCF Ratio
1.361.362.171.381.50-13.36
Asset Turnover
0.000.000.270.250.170.14
Quick Ratio
7.877.8710.274.103.965.33
Current Ratio
8.728.7211.144.624.415.69
Return on Equity (ROE)
90.27%90.27%58.08%-2302.82%-263.32%-445.64%
Return on Assets (ROA)
-54.53%-54.53%-40.07%-52.54%-47.58%-43.00%
Return on Invested Capital (ROIC)
-253.47%-253.47%-174.33%-205.38%-276.56%-153.96%
Return on Capital Employed (ROCE)
-59.99%-59.99%-44.76%-64.18%-57.30%-64.48%
Earnings Yield
-32.07%-31.09%-14.39%-8.46%-10.23%-7.53%
FCF Yield
-22.56%-21.70%-20.88%-7.20%-10.44%1.04%
Buyback Yield / Dilution
-2.12%-2.12%-24.69%-15.21%-8.58%-8.78%
Total Shareholder Return
-2.12%-2.12%-24.69%-15.21%-8.58%-8.78%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q